Cytodyn Inc (CYDY)

[weasel6667]

Can someone explain to me how this numbers add up?
Nader stated that our trial had 87 dead patients near the trial finish line.
Based on the knowledge that usually 30% of patients died in the placebo arm at other similar COVID trials, some folks calculated that the overall reduction of mortality at CD12 should be somewhere around 40%.
Now we know that we have "only" a 24% mortality reduction at the critical patients population.

following possibilities:
1. Nader told us nonsense with the 87 patients or this number was misleading.
2. We had unusual healthy patients at the placebo arm (mortality lower than 30%)
3.This means we should have mind blowing results at the severe patient population, to "reach" the calculated 40% reduction of the whole CD12 trial.

Which is it?